EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for PHIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 -1.342
March 31, 2026 -1.438
December 31, 2025 -1.504
September 30, 2025 -2.238
June 30, 2025 -3.340
March 31, 2025 -6.506
December 31, 2024 -10.33
September 30, 2024 -13.94
June 30, 2024 -22.66
March 31, 2024 -32.31
December 31, 2023 -56.46
September 30, 2023 -73.49
June 30, 2023 -91.50
March 31, 2023 -98.24
December 31, 2022 -90.89
September 30, 2022 -96.85
June 30, 2022 -98.45
March 31, 2022 -99.87
December 31, 2021 -113.29
September 30, 2021 -131.75
June 30, 2021 -145.03
March 31, 2021 -159.95
December 31, 2020 -268.71
September 30, 2020 -729.10
June 30, 2020 -1175.47
Date Value
March 31, 2020 -1638.07
December 31, 2019 -2111.25
September 30, 2019 -2205.46
June 30, 2019 -3744.75
March 31, 2019 -5998.27
December 31, 2018 -10713.56
September 30, 2018 -15110.88
June 30, 2018 -19337.49
March 31, 2018 -23255.04
December 31, 2017 -33689.30
September 30, 2017 -64331.39
June 30, 2017 -78271.97
March 31, 2017 -91797.95
December 31, 2016 -96228.00
September 30, 2016 -84348.00
June 30, 2016 -87912.00
March 31, 2016 -97416.00
December 31, 2015 -154440.0
September 30, 2015 -207900.0
June 30, 2015 -285120.0
March 31, 2015 -392040.0
December 31, 2014 -504900.0
September 30, 2014 -615384.0
June 30, 2014 -692604.0
March 31, 2014 -787644.0

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Imunon, Inc. -3.843
Agenus, Inc. 2.651
Amgen, Inc. 16.10
Anika Therapeutics, Inc. -0.2741
BioCryst Pharmaceuticals, Inc. -1.504